Mar 12, 2026 07:31AM
Mar 12, 2026 07:30AM
Dec 11, 2025 07:47AM
Nov 6, 2025 04:02PM
Sep 10, 2025 07:47AM
Sep 10, 2025 07:47AM
Aug 7, 2025 04:06PM Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
May 29, 2025 08:00AM
May 13, 2025 04:06PM
Mar 13, 2025 04:07PM
Jan 28, 2025 08:03AM
Jan 28, 2025 08:00AM
Jan 10, 2025 08:00AM
Nov 18, 2024 08:00AM Intensity Therapeutics (INTS) Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial
Nov 18, 2024 08:00AM
May 10, 2024 08:03AM
May 10, 2024 08:01AM
Mar 14, 2024 04:09PM
Jan 3, 2024 08:05AM
Jan 3, 2024 08:01AM
Sep 7, 2023 08:02AM Intensity Therapeutics (INTS) Granted Orphan Drug Designation for the three key ingredients in INT230-6
Sep 7, 2023 08:01AM
Jun 6, 2023 07:35AM
Jun 3, 2023 08:00AM
Nov 10, 2022 07:01AM

322,222 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All